Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM
暂无分享，去创建一个
J. Uhm | R. Arusell | J. Buckner | P. Brown | E. Galanis | K. Ballman | J. Reid | R. Morton | M. Ames | C. Giannini | K. Jaeckle | D. Wender | Stephanie L. Safgren | P. Schomberg | R. McGovern | J. Hammack | D. Nikcevich